mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / mircera

Mircera

Methoxy Polyethylene Glycol-Epoetin Beta
  o--o
   \/
   /\
  o--o

Methoxy Polyethylene Glycol-Epoetin Beta is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyMethoxy Polyethylene Glycol-Epoetin Beta
administration routeIntravenous
price comparison status2 snapshots
safety signal rating54 / 100
Erythropoiesis-stimulating Agent [EPC]openFDA NDC seedopenFDA NDC50 ug/.3mL
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Erythropoiesis-stimulating Agent [EPC].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 804 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Moderate Growth3M: +1.2%12M: +6.2%
Jul 2025
▂▃▃▄▄▅▅▇▇██
Jun 2026
Jan 2026$23.79
Feb 2026$23.89
Mar 2026$24.16
Apr 2026$24.25
May 2026$24.35
Jun 2026$24.45
01 / chemistryVifor (International) Inc.

Ingredient Breakdown

active moietyMethoxy Polyethylene Glycol-Epoetin Beta
formulationIntravenous Erythropoiesis-stimulating Agent [EPC]
mechanism of action

Erythropoiesis-stimulating Agent [EPC]

available strengths
50 ug/.3mL

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Use the ingredient name as the anchor before comparing any brand or pharmacy listing.
  2. Read the official label for route-specific directions, contraindications, and storage.
  3. Ask a clinician or pharmacist before substituting products across countries or formulations.
  4. Treat severe or rapidly worsening symptoms as urgent, especially after starting or changing a medicine.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches
MirceraMirceraMirceraMircera